These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36033384)

  • 21. Advanced Hepatocellular Cancer Treated with Sorafenib and Novel Inflammatory Markers.
    Gulmez A; Harputluoglu H
    J Gastrointest Cancer; 2023 Mar; 54(1):11-19. PubMed ID: 35119620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma.
    Hoppe M; Gersey ZC; Muthiah N; Abdallah HM; Plute T; Abou-Al-Shaar H; Wang EW; Snyderman CH; Zenonos GA; Gardner PA
    Neurosurg Focus; 2024 May; 56(5):E16. PubMed ID: 38691858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
    Matsubara S; Mabuchi S; Takeda Y; Kawahara N; Kobayashi H
    PLoS One; 2021; 16(5):e0248871. PubMed ID: 33989285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
    Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
    BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
    Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Predictive Value of Systemic Inflammatory Factors in Advanced, Metastatic Esophageal Squamous Cell Carcinoma Patients Treated with Camrelizumab.
    Liu J; Gao D; Li J; Hu G; Liu J; Liu D
    Onco Targets Ther; 2022; 15():1161-1170. PubMed ID: 36238132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood biomarkers predict outcomes in patients with hepatocellular carcinoma treated with immune checkpoint Inhibitors: A pooled analysis of 44 retrospective sudies.
    Zhang L; Feng J; Kuang T; Chai D; Qiu Z; Deng W; Dong K; Zhao K; Wang W
    Int Immunopharmacol; 2023 May; 118():110019. PubMed ID: 36933492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
    Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
    Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic Immune-inflammation Index is the Best Prognostic Factor in Patients with Advanced Stage Adenocarcinoma of the Lung Treated with Pemetrexed.
    Bilgetekin I; Basal FB
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):933-939. PubMed ID: 33036677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy.
    Park Y; Chang AR
    Korean J Gastroenterol; 2022 Jun; 79(6):252-259. PubMed ID: 35746839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
    Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
    World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective.
    Zheng X; Ye B; Gou Y; Li Z; Chen C; Liao F; Liu X; Qin S
    Transl Cancer Res; 2021 Mar; 10(3):1261-1272. PubMed ID: 35116453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab.
    Jiang L; Fang J; Ding J
    Cancer Manag Res; 2020; 12():475-484. PubMed ID: 32021460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma.
    Aktepe OH; Güner G; Güven DC; Şahin TK; Ardıç FS; Yüce D; Yalçın Ş; Erman M
    Turk J Med Sci; 2021 Apr; 51(2):757-765. PubMed ID: 33350295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.
    Yang YT; Jiang JH; Yang HJ; Wu ZJ; Xiao ZM; Xiang BD
    Sci Rep; 2018 Feb; 8(1):2535. PubMed ID: 29416061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-to-lymphocyte ratio acts as an independent risk factor for patients with hepatitis B virus-related hepatocellular carcinoma who received transarterial chemoembolization.
    Tian XC; Liu XL; Zeng FR; Chen Z; Wu DH
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2302-9. PubMed ID: 27338055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.